TY  - GEN
AU  - Barrajon,Enrique
TI  - Natural Compounds as New Cancer Treatments
SN  - books978-3-03921-366-5
PY  - 2019///
PB  - MDPI - Multidisciplinary Digital Publishing Institute
KW  - microbiota
KW  - treatment
KW  - n/a
KW  - sulforaphane
KW  - synergy
KW  - epigenetic
KW  - natural compound
KW  - xenohormesis
KW  - anticancer
KW  - miR-663
KW  - tyrosine kinase inhibitors
KW  - acetylation
KW  - epidemiology
KW  - double-blinded
KW  - inflammation
KW  - bladder cancer
KW  - polypharmacology
KW  - animal model
KW  - synbiotics
KW  - resveratrol
KW  - royal jelly
KW  - 5-aza-2’-deoxycytine
KW  - saponins
KW  - phenolics
KW  - cardiovascular disease
KW  - antioxidant
KW  - colorectal cancer
KW  - trypsin inhibitors
KW  - seeds
KW  - green tea
KW  - Gac
KW  - randomized clinical trial
KW  - melanoma
KW  - adverse events
KW  - extraction
KW  - microbiome
KW  - Momordica cochinchinensis
KW  - freeze dried extract
KW  - renal cell carcinoma
KW  - methylation
KW  - cancer
KW  - probiotics
N1  - Open Access
N2  - Cancer remains one of the main causes of morbidity and mortality worldwide. Although many pharmacological and clinical advances have been made, there is a constant need for new molecules to improve the overall options for treatment. Natural compounds from animal, microbial, vegetal, or fungal origin represent countless sources of new compounds that can be used as anticancer drugs, provided their activity, bioavailability, and toxicity are adequate. This book aims to compile both original articles and reviews that cover the most recent advances in the use of natural compounds for cancer treatment, and provide new objectives and advice for future research in the field of biological activity of natural compounds
UR  - https://mdpi.com/books/pdfview/book/1565
UR  - https://directory.doabooks.org/handle/20.500.12854/54350
ER  -